These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 9622205)

  • 1. Rat central ORL-1 receptor uncouples from adenylyl cyclase during membrane preparation.
    Okawa H; Hirst RA; Smart D; McKnight AT; Lambert DG
    Neurosci Lett; 1998 Apr; 246(1):49-52. PubMed ID: 9622205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recognition and activation of the opioid receptor-like ORL 1 receptor by nociceptin, nociceptin analogs and opioids.
    Butour JL; Moisand C; Mazarguil H; Mollereau C; Meunier JC
    Eur J Pharmacol; 1997 Feb; 321(1):97-103. PubMed ID: 9083791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the binding of [(3)H]nociceptin/orphaninFQ(1-13)NH(2), [(3)H]nociceptin/orphaninFQ(1-17)OH and [(125)I]Tyr(14)nociceptin/orphaninFQ(1-17)OH to recombinant human and native rat cerebrocortical nociceptin/orphanin FQ receptors.
    Hashiba E; Lambert DG; Farkas J; Toth G; Smith G
    Neurosci Lett; 2002 Aug; 328(1):5-8. PubMed ID: 12123846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterisation of the rat cerebella CB1 receptor using SR141716A, a central cannabinoid receptor antagonist.
    Hirst RA; Almond SL; Lambert DG
    Neurosci Lett; 1996 Dec; 220(2):101-4. PubMed ID: 8981483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [125I][Tyr14]Orphanin binding to rat brain: evidence for labelling the opioid-receptor-like 1 (ORL1).
    Foddi MC; Mennini T
    Neurosci Lett; 1997 Jul; 230(2):105-8. PubMed ID: 9259475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological profile of the cyclic nociceptin/orphanin FQ analogues c[Cys10,14]N/OFQ(1-14)NH2 and c[Nphe1,Cys10,14]N/OFQ(1-14)NH2.
    Kitayama M; Barnes TA; Carra G; McDonald J; Calo G; Guerrini R; Rowbotham DJ; Smith G; Lambert DG
    Naunyn Schmiedebergs Arch Pharmacol; 2003 Dec; 368(6):528-37. PubMed ID: 14598020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [3H]ac-RYYRWK-NH2, a novel specific radioligand for the nociceptin/orphanin FQ receptor.
    Thomsen C; Valsborg JS; Platou J; Martin J; Foged C; Johansen NL; Olsen UB; Madsen K
    Naunyn Schmiedebergs Arch Pharmacol; 2000 Dec; 362(6):538-45. PubMed ID: 11138846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological characterization of the nociceptin/orphanin FQ receptor antagonist SB-612111 [(-)-cis-1-methyl-7-[[4-(2,6-dichlorophenyl)piperidin-1-yl]methyl]-6,7,8,9-tetrahydro-5H-benzocyclohepten-5-ol]: in vitro studies.
    Spagnolo B; Carrà G; Fantin M; Fischetti C; Hebbes C; McDonald J; Barnes TA; Rizzi A; Trapella C; Fanton G; Morari M; Lambert DG; Regoli D; Calò G
    J Pharmacol Exp Ther; 2007 Jun; 321(3):961-7. PubMed ID: 17329552
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nociceptin (orphanin FQ): high-affinity and high-capacity binding site coupled to low-potency stimulation of guanylyl-5'-O-(gamma-thio)-triphosphate binding in rat brain membranes.
    Albrecht E; Samovilova NN; Oswald S; Baeger I; Berger H
    J Pharmacol Exp Ther; 1998 Aug; 286(2):896-902. PubMed ID: 9694948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Helix-constrained nociceptin peptides are potent agonists and antagonists of ORL-1 and nociception.
    Lohman RJ; Harrison RS; Ruiz-Gómez G; Hoang HN; Shepherd NE; Chow S; Hill TA; Madala PK; Fairlie DP
    Vitam Horm; 2015; 97():1-55. PubMed ID: 25677767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro characterization of Ac-RYYRWK-NH(2), Ac-RYYRIK-NH(2) and [Phe1Psi(CH(2)-NH)Gly2] nociceptin(1-13)NH(2) at rat native and recombinant ORL(1) receptors.
    Mason SL; Ho M; Nicholson J; McKnight AT
    Neuropeptides; 2001; 35(5-6):244-56. PubMed ID: 12030809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunoglobulin G1 Fc fragment-tagged human opioid receptor-like receptor retains the ability to inhibit cAMP accumulation.
    Yung LY; Tsim KW; Pei G; Wong YH
    Biol Signals Recept; 2000; 9(5):240-7. PubMed ID: 10965058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nociceptin activation of the human ORL1 receptor expressed in Chinese hamster ovary cells: functional homology with opioid receptors.
    Fawzi AB; Zhang H; Weig B; Hawes B; Graziano MP
    Eur J Pharmacol; 1997 Oct; 336(2-3):233-42. PubMed ID: 9384238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction of [3H]orphanin FQ and 125I-Tyr14-orphanin FQ with the orphanin FQ receptor: kinetics and modulation by cations and guanine nucleotides.
    Ardati A; Henningsen RA; Higelin J; Reinscheid RK; Civelli O; Monsma FJ
    Mol Pharmacol; 1997 May; 51(5):816-24. PubMed ID: 9145920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological studies on the "orphan" opioid receptor in central and peripheral sites.
    Nicholson JR; Paterson SJ; Menzies JR; Corbett AD; McKnight AT
    Can J Physiol Pharmacol; 1998 Mar; 76(3):304-13. PubMed ID: 9673794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the effects of [Phe1psi(CH2-NH)Gly2]nociceptin(1-13)NH2 in rat brain, rat vas deferens and CHO cells expressing recombinant human nociceptin receptors.
    Okawa H; Nicol B; Bigoni R; Hirst RA; Calo G; Guerrini R; Rowbotham DJ; Smart D; McKnight AT; Lambert DG
    Br J Pharmacol; 1999 May; 127(1):123-30. PubMed ID: 10369464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterisation and comparison of novel ligands for the nociceptin/orphanin FQ receptor.
    Hashiba E; Harrison C; Galo' G; Guerrini R; Rowbotham DJ; Smith G; Lambert DG
    Naunyn Schmiedebergs Arch Pharmacol; 2001 Jan; 363(1):28-33. PubMed ID: 11191833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A potent and highly selective nonpeptidyl nociceptin/orphanin FQ receptor (ORL1) antagonist: J-113397.
    Ozaki S; Kawamoto H; Itoh Y; Miyaji M; Iwasawa Y; Ohta H
    Eur J Pharmacol; 2000 Jan; 387(3):R17-8. PubMed ID: 10650183
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nociceptin (ORL-1) and mu-opioid receptors mediate mitogen-activated protein kinase activation in CHO cells through a Gi-coupled signaling pathway: evidence for distinct mechanisms of agonist-mediated desensitization.
    Hawes BE; Fried S; Yao X; Weig B; Graziano MP
    J Neurochem; 1998 Sep; 71(3):1024-33. PubMed ID: 9721727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antagonistic effects of [Nphe1]nociceptin(1-13)NH2 on nociceptin receptor mediated inhibition of cAMP formation in Chinese hamster ovary cells stably expressing the recombinant human nociceptin receptor.
    Hashimoto Y; Caló G; Guerrini R; Smith G; Lambert DG
    Neurosci Lett; 2000 Jan; 278(1-2):109-12. PubMed ID: 10643813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.